Loss of heterozigosity for 1p chromosome in neuroblastoma

C. Valenti, D. Di Martino, B. De Bernardi, A. Garaventa, F. Bottini, G. P. Tonini

Research output: Contribution to journalArticle

Abstract

Neuroblastoma is characterized by non-random chromosome 1p deletion. About 70% of human neuroblastomas in advanced stages show loss of the short arm of chromosome 1. Moreover, the remaining neuroblastomas can have molecular deletion that are not detected by cytogenetic analysis. We studied loss of heterozigosity (LOH) on chromosome 1 in 26 neuroblastoma tissues belonging to patients in different stages of disease employing probes derived from microdissection and microcloning of the short arm of chromosome 1. LOH was found both in patients in stage 1 and in stage 4. Patients in stage 4 show consistent deletion at locus D1S94 corresponding to the chromosomal region 1p36.11-1p36.12. In this region could be located the putative neuroblastoma supressor gene. Combined analysis of LOH and MYCN gene amplification does not show relation between these two molecular abnormalities.

Original languageEnglish
Pages (from-to)227-231
Number of pages5
JournalClinical Chemistry and Enzymology Communications
Volume5
Issue number4-6
Publication statusPublished - 1993

Fingerprint

Chromosomes
Neuroblastoma
Chromosomes, Human, Pair 1
Microdissection
Chromosome Deletion
Gene Amplification
Cytogenetic Analysis
Genes
Tissue

Keywords

  • Chromosome 1
  • Loss-of-heterozigosity
  • MYCN oncogene
  • Neuroblastoma

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Valenti, C., Di Martino, D., De Bernardi, B., Garaventa, A., Bottini, F., & Tonini, G. P. (1993). Loss of heterozigosity for 1p chromosome in neuroblastoma. Clinical Chemistry and Enzymology Communications, 5(4-6), 227-231.

Loss of heterozigosity for 1p chromosome in neuroblastoma. / Valenti, C.; Di Martino, D.; De Bernardi, B.; Garaventa, A.; Bottini, F.; Tonini, G. P.

In: Clinical Chemistry and Enzymology Communications, Vol. 5, No. 4-6, 1993, p. 227-231.

Research output: Contribution to journalArticle

Valenti, C, Di Martino, D, De Bernardi, B, Garaventa, A, Bottini, F & Tonini, GP 1993, 'Loss of heterozigosity for 1p chromosome in neuroblastoma', Clinical Chemistry and Enzymology Communications, vol. 5, no. 4-6, pp. 227-231.
Valenti C, Di Martino D, De Bernardi B, Garaventa A, Bottini F, Tonini GP. Loss of heterozigosity for 1p chromosome in neuroblastoma. Clinical Chemistry and Enzymology Communications. 1993;5(4-6):227-231.
Valenti, C. ; Di Martino, D. ; De Bernardi, B. ; Garaventa, A. ; Bottini, F. ; Tonini, G. P. / Loss of heterozigosity for 1p chromosome in neuroblastoma. In: Clinical Chemistry and Enzymology Communications. 1993 ; Vol. 5, No. 4-6. pp. 227-231.
@article{ddfa1b2c6ede4f37a940e8af02fd483d,
title = "Loss of heterozigosity for 1p chromosome in neuroblastoma",
abstract = "Neuroblastoma is characterized by non-random chromosome 1p deletion. About 70{\%} of human neuroblastomas in advanced stages show loss of the short arm of chromosome 1. Moreover, the remaining neuroblastomas can have molecular deletion that are not detected by cytogenetic analysis. We studied loss of heterozigosity (LOH) on chromosome 1 in 26 neuroblastoma tissues belonging to patients in different stages of disease employing probes derived from microdissection and microcloning of the short arm of chromosome 1. LOH was found both in patients in stage 1 and in stage 4. Patients in stage 4 show consistent deletion at locus D1S94 corresponding to the chromosomal region 1p36.11-1p36.12. In this region could be located the putative neuroblastoma supressor gene. Combined analysis of LOH and MYCN gene amplification does not show relation between these two molecular abnormalities.",
keywords = "Chromosome 1, Loss-of-heterozigosity, MYCN oncogene, Neuroblastoma",
author = "C. Valenti and {Di Martino}, D. and {De Bernardi}, B. and A. Garaventa and F. Bottini and Tonini, {G. P.}",
year = "1993",
language = "English",
volume = "5",
pages = "227--231",
journal = "Clinical Chemistry and Enzymology Communications",
issn = "0892-2187",
publisher = "Harwood Academic Publishers",
number = "4-6",

}

TY - JOUR

T1 - Loss of heterozigosity for 1p chromosome in neuroblastoma

AU - Valenti, C.

AU - Di Martino, D.

AU - De Bernardi, B.

AU - Garaventa, A.

AU - Bottini, F.

AU - Tonini, G. P.

PY - 1993

Y1 - 1993

N2 - Neuroblastoma is characterized by non-random chromosome 1p deletion. About 70% of human neuroblastomas in advanced stages show loss of the short arm of chromosome 1. Moreover, the remaining neuroblastomas can have molecular deletion that are not detected by cytogenetic analysis. We studied loss of heterozigosity (LOH) on chromosome 1 in 26 neuroblastoma tissues belonging to patients in different stages of disease employing probes derived from microdissection and microcloning of the short arm of chromosome 1. LOH was found both in patients in stage 1 and in stage 4. Patients in stage 4 show consistent deletion at locus D1S94 corresponding to the chromosomal region 1p36.11-1p36.12. In this region could be located the putative neuroblastoma supressor gene. Combined analysis of LOH and MYCN gene amplification does not show relation between these two molecular abnormalities.

AB - Neuroblastoma is characterized by non-random chromosome 1p deletion. About 70% of human neuroblastomas in advanced stages show loss of the short arm of chromosome 1. Moreover, the remaining neuroblastomas can have molecular deletion that are not detected by cytogenetic analysis. We studied loss of heterozigosity (LOH) on chromosome 1 in 26 neuroblastoma tissues belonging to patients in different stages of disease employing probes derived from microdissection and microcloning of the short arm of chromosome 1. LOH was found both in patients in stage 1 and in stage 4. Patients in stage 4 show consistent deletion at locus D1S94 corresponding to the chromosomal region 1p36.11-1p36.12. In this region could be located the putative neuroblastoma supressor gene. Combined analysis of LOH and MYCN gene amplification does not show relation between these two molecular abnormalities.

KW - Chromosome 1

KW - Loss-of-heterozigosity

KW - MYCN oncogene

KW - Neuroblastoma

UR - http://www.scopus.com/inward/record.url?scp=0027745615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027745615&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027745615

VL - 5

SP - 227

EP - 231

JO - Clinical Chemistry and Enzymology Communications

JF - Clinical Chemistry and Enzymology Communications

SN - 0892-2187

IS - 4-6

ER -